LHDX Earnings & Forecasts - Benzinga

SPY769.86+0.03%QQQ749.55−0.00%BTC/USD86,405.27−0.13%DIA511.70+0.12%GLD380.52+0.10%TLT77.53+0.06%

LHDX

LHDXNasdaq Private Market

Private market price is not available

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

LHDX Earnings & Forecasts - Benzinga

LHDX Earnings & Forecasts

LHDX (LHDX) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

LHDX Guidance

Recent Earnings Results

Metric	Q3 '22	Q2 '22	Q1 '22	Q4 '21
Earnings Per Share (Non-GAAP)
Estimate	$-0.38	$-0.34	$-0.08	$-0.55
Actual	$-0.38	$-0.45	$0.40	$0.01
Surprise	0.00%	-32.4%	+600.0%	+101.8%
Revenue
Estimate	$32.8M	$30.1M	$85.3M	$40.6M
Actual	$34.4M	$26.1M	$90.5M	$61.1M
Surprise	+4.88%	-13.0%	+6.00%	+50.4%

Earnings & Guidance News

S&P 500 Rises Over 0.5%; US Pending Home Sales Increase Sharply

U.S. stocks traded higher toward the end of trading, with the NASDAQ Composite gaining around 100 points on Monday. The Dow traded up 0.40% to 32,949.23 while the NASDAQ rose 0.93% to 11,500.59. The S&P 500 also rose, gaining, 0.58% to 3,992.95.

Lisa Levin

Nasdaq Rises 80 Points; TEGNA Shares Plunge

U.S. stocks traded higher midway through trading, with the NASDAQ Composite gaining around 80 points on Monday. The Dow traded up 0.15% to 32,867.61 while the NASDAQ rose 0.70% to 11,475.20. The S&P 500 also rose, gaining, 0.34% to 3,983.41.

Lisa Levin

Crude Oil Rises 1.5%; NeoGenomics Shares Spike Higher

U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded down 0.03% to 33,036.50 while the NASDAQ rose 0.46% to 11,559.92. The S&P 500 also rose, gaining, 0.22% to 3,999.74.

Lisa Levin

US Stocks Turn Lower; Dow Drops 150 Points

U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Thursday. The Dow traded down 0.47% to 32,889.30 while the NASDAQ fell 0.47% to 11,452.63. The S&P 500 also fell, dropping, 0.32% to 3,978.24.

Lisa Levin

Looking Into Lucira Health's Return On Capital Employed

Benzinga Insights

PRO
UPDATE: Lucira Health Q3 EPS $(0.38), Inline, Sales $34.39M Beat $32.79M Estimate

Lucira Health (NASDAQ:LHDX) reported quarterly losses of $(0.38) per share which met the analyst consensus estimate. This is a 19.15 percent increase over losses of $(0.47) per share from the same period last year. The

Benzinga Newsdesk

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q3	Nov 14, 2022	$-0.38	$-0.38	0.00 %
Q2	Aug 15, 2022	$-0.45	$-0.34	-32.4 %
Q1	May 12, 2022	$0.40	$-0.08	600.0 %
Q4	Mar 10, 2022	$0.01	$-0.55	101.8 %

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %
Q3	Nov 14, 2022	$34.39M	$32.79M	4.88 %
Q2	Aug 15, 2022	$26.15M	$30.05M	-13.0 %
Q1	May 12, 2022	$90.47M	$85.35M	6.00 %
Q4	Mar 10, 2022	$61.12M	$40.65M	50.4 %